+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Acute Respiratory Distress Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767509
  • Report
  • April 2019
  • Region: Global
  • 252 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Altor BioScience Corp
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • Faron Pharmaceuticals Oy
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
The global clinical trial report- “2019 Acute Respiratory Distress Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Acute Respiratory Distress Syndrome. It presents in-depth analysis of Acute Respiratory Distress Syndrome clinical trials across markets and companies. The research work is for providing complete understanding into trends in Acute Respiratory Distress Syndrome.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Acute Respiratory Distress Syndrome clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Acute Respiratory Distress Syndrome

The research work is prepared through extensive and continuous research on Acute Respiratory Distress Syndrome trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Acute Respiratory Distress Syndrome patients are identified
  • The report includes panorama of Acute Respiratory Distress Syndrome clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Acute Respiratory Distress Syndrome clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Altor BioScience Corp
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • Faron Pharmaceuticals Oy
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Acute Respiratory Distress Syndrome Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Acute Respiratory Distress Syndrome Clinical Trials by Region
2.2.2 Average Enrollment of Acute Respiratory Distress Syndrome Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Acute Respiratory Distress Syndrome Treatment, 2019

3. Region wise Acute Respiratory Distress Syndrome Clinical Trials
3.1 Asia Pacific Acute Respiratory Distress Syndrome Clinical Trials by Country
3.2 Europe Acute Respiratory Distress Syndrome Clinical Trials by Country
3.3 North America Acute Respiratory Distress Syndrome Clinical Trials by Country
3.4 Middle East and Africa Acute Respiratory Distress Syndrome Clinical Trials by Country
3.5 South and Central America Acute Respiratory Distress Syndrome Clinical Trials by Country

4. Acute Respiratory Distress Syndrome Clinical Trial Trends
4.1 Start Year wise Acute Respiratory Distress Syndrome Clinical Trials
4.2 Phase wise Acute Respiratory Distress Syndrome Clinical Trials
4.3 Trial Status wise Acute Respiratory Distress Syndrome Clinical Trials
4.4 Trial Type wise Acute Respiratory Distress Syndrome Clinical Trials

5. Acute Respiratory Distress Syndrome Average Enrollment Trends
5.1 Average Enrollment in Acute Respiratory Distress Syndrome Trials by Year
5.2 Average Enrollment in Acute Respiratory Distress Syndrome Trials by Phase
5.3 Average Enrollment in Acute Respiratory Distress Syndrome Trials by Status
5.4 Average Enrollment in Acute Respiratory Distress Syndrome Trials by Type of Trial

6. Companies Participating in Acute Respiratory Distress Syndrome Clinical Trials
6.1 Acute Respiratory Distress Syndrome Trials by Sponsor Type
6.2 Acute Respiratory Distress Syndrome Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Acute Respiratory Distress Syndrome Trials- Phase 1
7.2 Acute Respiratory Distress Syndrome Trials- Phase 2
7.3 Acute Respiratory Distress Syndrome Trials- Phase 3
7.4 Acute Respiratory Distress Syndrome Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Acute Respiratory Distress Syndrome Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Acute Respiratory Distress Syndrome Clinical Trials and Enrolment
Figure 5: Europe - Country wise Acute Respiratory Distress Syndrome Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Acute Respiratory Distress Syndrome Clinical Trials and Enrolment
Figure 7: North America - Country wise Acute Respiratory Distress Syndrome Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Acute Respiratory Distress Syndrome Clinical Trials and Enrolment
Figure 9: Acute Respiratory Distress Syndrome Clinical Trials by Phase
Figure 10: Acute Respiratory Distress Syndrome Clinical Trials by Trial Status
Figure 11: Acute Respiratory Distress Syndrome Clinical Trials by Type
Figure 12: Acute Respiratory Distress Syndrome Clinical Trials by Sponsor Type
Figure 13: Acute Respiratory Distress Syndrome Clinical Trials by Leading Sponsors
Figure 14: Acute Respiratory Distress Syndrome Average Enrollment by Phase
Figure 15: Acute Respiratory Distress Syndrome Average Enrollment by Trial Status
Figure 16: Acute Respiratory Distress Syndrome Average Enrollment by Type
Figure 17: Acute Respiratory Distress Syndrome- Average Enrolment by Type of Sponsors
Figure 18: Acute Respiratory Distress Syndrome- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Acute Respiratory Distress Syndrome Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Acute Respiratory Distress Syndrome Clinical Trials and Enrolment
Table 5: Europe - Country wise Acute Respiratory Distress Syndrome Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Acute Respiratory Distress Syndrome Clinical Trials and Enrolment
Table 7: North America - Country wise Acute Respiratory Distress Syndrome Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Acute Respiratory Distress Syndrome Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Acute Respiratory Distress Syndrome Average Enrollment by Phase
Table 15: Acute Respiratory Distress Syndrome Average Enrollment by Trial Status
Table 16: Acute Respiratory Distress Syndrome Average Enrollment by Type
Table 17: Acute Respiratory Distress Syndrome- Average Enrolment by Type of Sponsors
Table 18: Acute Respiratory Distress Syndrome- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • Altor BioScience Corp
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • Faron Pharmaceuticals Oy
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MallInckrodt Plc
  • Savara Inc
  • THERAMetrics holding AG
  • Windtree Therapeutics Inc
Note: Product cover images may vary from those shown
Adroll
adroll